786-817-6690 
Contact Us
Bio-Tissue, a business unit of TissueTech, Inc., today announced the global online availability of its newest product Cliradex Light advanced foaming eyelid cleanser on its newly redesigned website, www.cliradex.com. International purchases may be directed to Amazon Marketplace. Cliradex Light – which was launched last year and quickly realized high consumer and physician office demand – is […]
Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound Allograft – Amniox’s proprietary cryopreserved Umbilical Cord and Amniotic Membrane (UC/AM) product for chronic wound management – were […]
ATLANTA, GA – June 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane for wound healing and soft-tissue repair. Intalere is a professional supply chain company offering a comprehensive […]
Proprietary technology demonstrates significant improvement in short-term and long-term outcomes. ATLANTA – July 10, 2017 – AMNIOX Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in lumbar microdiscectomy surgery was published in the May 2017 online issue of Clinical Spine Surgery. The […]
MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary liaison for medical affairs, has more than 25 years of healthcare industry-based experience, most recently […]
RESPINA umbilical cord/amniotic membrane matrix for microdiscectomy earns 2017 Spine Technology Award ORLANDO – October 26, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the introduction of RESPINA its cryopreserved umbilical cord/amniotic membrane matrix at the North American Spine Society’s (NASS) annual meeting in Orlando, FL, October 25 – 27. AMNIOX Medical’s proprietary amniotic membrane technology has […]
Company has more than 40 issued patents MIAMI – September 14, 2017 – TissueTech Inc. announced today that it has been awarded four patents by the U.S. Patent Trademark Office. Two of the patents cover methods of promoting bone formation and the others cover methods for lyophilizing and sterilizing placental tissue. “TissueTech continues to maintain its […]
Arnott brings experience in a wide range of global healthcare businesses MIAMI – August 3, 2017 – TissueTech Inc. announced today that it has named John Arnott to its Board of Directors. Mr. Arnott was most recently Operating Partner and Executive Chairman of multiple portfolio companies for The Riverside Company, one of largest and oldest […]